Ovarian cancer in 2010
Novel targeting strategies using recombinant antibodies for early diagnosis and therapy of ovarian cancer
Patient-specific tumor biology-based selection of ovarian cancer therapy
Robotic-assisted minimally invasive surgery and ovarian cancer
Diet can influence ovarian cancer survival, study suggests
Cancer antigen 125 levels may predict survival and recurrence in high-risk ovarian cancer
Study suggests elderly women with ovarian cancer receive slower specialist referral
Analgesic painkillers may decrease estrogen levels, possibly contributing to reduced ovarian cancer risk
Can we accurately predict ovarian cancer from its symptoms?
How effective are current ovarian cancer markers in predicting the onset of ovarian cancer?
Using in vitro cultures of fallopian tube epithelial cells in the study of serous cancers
Personalizing therapy for ovarian cancer
Oophorectomy as a preventative measure for ovarian cancer
Role of secondary cytoreduction in recurrent ovarian cancer
Fertility preservation in ovarian cancer
Evidence-based chemotherapeutic management of potentially platinum-sensitive recurrent ovarian cancer
Antiangiogenic therapies in ovarian cancer
Could gene therapy be the future for muscular dystrophy?
Common antibiotic halves HIV death rates in DART trial
Experimental vaccine against inflammatory bowel disease and colon cancer
Large-scale trial suggests ethosuximide as best treatment for absence epilepsy
Combination of gemcitabine and cisplatin demonstrates positive results in women suffering from advanced endometrial cancer
EMA approves Xeloda® for the treatment of early colon cancer
Clostridium difficile infection
Acknowledgements